Thyroid hormone could inhibit lung fibrosis by improving epithelial mitochondrial function (Yu, Tzouvelekis et al., 2018), and BLM-mediated IPF was found to be dependent on the IL-17 pathway (Wilson and Wynn 2009). Here, IL17A is linked to pulmonary fibrosis.